Revenue (Quarterly) Chart

View Revenue (Quarterly) for DIOFF.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Revenue (Quarterly) Chart
Start Trial

Historical Revenue (Quarterly) Data

View and export this data back to 2007. Start Trial.
Date Value
June 30, 2026 71.23M
March 31, 2026 72.53M
December 31, 2025 71.12M
September 30, 2025 69.98M
June 30, 2025 68.90M
March 31, 2025 61.93M
December 31, 2024 58.63M
September 30, 2024 59.68M
June 30, 2024 59.40M
March 31, 2024 61.47M
December 31, 2023 60.54M
September 30, 2023 57.43M
June 30, 2023 58.85M
March 31, 2023 59.10M
December 31, 2022 52.93M
September 30, 2022 53.00M
June 30, 2022 55.23M
March 31, 2022 57.70M
December 31, 2021 56.42M
September 30, 2021 55.52M
June 30, 2021 59.84M
March 31, 2021 57.48M
December 31, 2020 54.81M
September 30, 2020 53.86M
June 30, 2020 46.46M
Date Value
March 31, 2020 49.37M
December 31, 2019 48.66M
September 30, 2019 48.49M
June 30, 2019 49.13M
March 31, 2019 49.81M
December 31, 2018 49.42M
September 30, 2018 52.20M
June 30, 2018 51.40M
March 31, 2018 55.47M
December 31, 2017 53.26M
September 30, 2017 53.51M
June 30, 2017 49.42M
March 31, 2017 45.40M
December 31, 2016 37.25M
September 30, 2016 39.31M
June 30, 2016 40.67M
March 31, 2016 39.60M
December 31, 2015 39.30M
September 30, 2015 38.19M
June 30, 2015 39.19M
March 31, 2015 39.32M
December 31, 2014 44.28M
September 30, 2014 46.66M
June 30, 2014 50.14M
March 31, 2014 50.75M

Revenues Definition

Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.

Read full definition.

Revenue (Quarterly) Range, Past 5 Years

View Revenue (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Revenue (Quarterly) Benchmarks

View Revenue (Quarterly) Benchmarks
Start Trial
Castellum AB 258.43M
Pandox AB 233.33M
Fabege AB 119.82M
Gyrodyne LLC --
IRSA Inversiones y Representaciones SA 101.81M